Recent Updates
Recently added Catalysts
KRMD Positive Sentiment

KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026

Tuesday, October 20, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: KORU Medical Systems will release its third-quarter 2026 financial results on November 10, 2026. The Mahwah-based medical technology company specializes in large volume subcutaneous infusion solutions. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the findings.

Market Sentiment Analysis

POSITIVE FACTORS

  • KORU Medical is focused on innovative infusion solutions.
  • The company is preparing to report its financial results.
  • Management will engage with investors through a conference call.

Full Press Release Details

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2026 financial results on Tuesday, November 10, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discus

Frequently Asked Questions

When will KORU Medical report its Q3 2026 results?

KORU Medical will report its Q3 2026 results on November 10, 2026.

What time is the conference call for KORU Medical?

The conference call is scheduled for 4:30 p.m. ET on November 10, 2026.

What does KORU Medical specialize in?

KORU Medical focuses on large volume subcutaneous infusion solutions.

How can investors access the results announcement?

Investors can access the results via a conference call and webcast.

ShareAdd on Google
Tags: KRMD KORU Medical financial results conference call infusion solutions
Last updated: Oct 20, 2026

Biotech snapshot

Cash runway
$8M liquidity · $0M/mo burn
Low dilution risk